摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

{Ag(Me2{18}aneN2S4)}PF6 | 134535-71-0

中文名称
——
中文别名
——
英文名称
{Ag(Me2{18}aneN2S4)}PF6
英文别名
——
{Ag(Me2{18}aneN2S4)}PF6化学式
CAS
134535-71-0
化学式
C14H30AgN2S4*F6P
mdl
——
分子量
607.502
InChiKey
QFPZFMHCXNLCNO-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    6.16
  • 重原子数:
    28.0
  • 可旋转键数:
    0.0
  • 环数:
    5.0
  • sp3杂化的碳原子比例:
    1.0
  • 拓扑面积:
    3.24
  • 氢给体数:
    0.0
  • 氢受体数:
    1.0

反应信息

  • 作为产物:
    描述:
    7,16-dimethyl-1,4,10,13-tetrathia-7,16-diazacyclooctadecane 、 ammonium hexafluorophosphate 在 AgNO3 作用下, 以 甲醇 为溶剂, 以66%的产率得到{Ag(Me2{18}aneN2S4)}PF6
    参考文献:
    名称:
    Silver macrocyclic complexes: synthesis, crystal structures and redox properties of [Ag([18]aneN2S4)]PF6and [Ag(Me2[18]aneN2S4)]BPh4([18]aneN2S4= 1,4,10,13-tetrathia-7,16-diazacyclooctadecane, Me2[18]aneN2S4= 7,16-dimethyl-1,4,10,13-tetrathia-7,16-diazacyclooctadecane)
    摘要:
    Reaction of AgNO3 with one molar equivalent of [18]aneN2S4 (1,4,10,13-tetrathia-7,16-diazacyclooctadecane) or Me2[18]aneN2S4 (7,16-dimethyl analogue) in refluxing MeOH-H2O affords the complex cations [Ag([18]aneN2S4)]+ and [Ag(Me2[18]aneN2S4)]+ respectively. [Ag([18]aneN2S4)]PF6 crystallises in the orthorhombic space group Pcab with a = 16.7327(25), b = 17.5023(11), c = 14.7031(6) angstrom and Z = 8. The metal ion is bound to a highly distorted octahedral arrangement of the six macrocyclic donor atoms [Ag-S 2.630(4), 2.664(4), 2.719(4), 2.774(4) angstrom; Ag-N 2.533(10), 2.817(15) angstrom]. The complex cation adopts a rac configuration in which the two S-N-S linkages are bound meridionally to the metal ion. [Ag(Me2[18]aneN2S4)]BPh4 crystallises in the monoclinic space group P2(1)/n with a = 10.7529(15), b = 19.0571(28), c = 18.9360(22) angstrom, beta = 106.035(10)degrees and Z = 4. The cation is disordered and shows two different configurations. The major [70.8(8)%] component shows an unusual kite-based pyramidal geometry with Ag(I) bound via a periplanar arrangement of four S-donor atoms [Ag-S(1) 2.583(4), Ag-S(4) 2.819(3), Ag-S(10) 2.663(4), Ag-S(13) 2.673(4) angstrom] and one apical N-donor atom [Ag-N(7) 2.517(11) angstrom]. The second N-donor atom does not interact with the metal centre [Ag ... N(16) 3.684(11) angstrom]. In view of the asymmetric bond length distribution, the overall stereochemistry may alternatively be described as tetrahedral through S(1), N(7), S(10) and S(13), with S(4) interacting more weakly at long range. Although this complex is severely distorted, it is clear that unlike in [Ag([18]aneN2S4)]+, the S(4)-N(7)-S(10) linkage in [Ag(Me2[18]aneN2S4)]+ binds facially to the Ag(I) centre to give a distorted meso isomer. The minor [29.2(8)%] component differs only in the orientation of the S(1), N(16') and S(13) linkage. Although the C-C and C-S bond lengths in this region were constrained, it is clear that N(16') is directed towards, and is co-ordinated to the Ag(I) centre [Ag-N(16') 2.778(10) angstrom], giving an octahedral complex in a genuine meso configuration. [Ag([18]aneN2S4)]+ shows a reversible Ag(I)-Ag(II) couple at E1/2 = + 0.65 V and a quasi-reversible Ag(I)-Ag0 couple at E1/2 = -0.74 V while [Ag(Me2[18]aneN2S4)]+ shows an irreversible Ag(I)-Ag(II) couple at E(pa) = +0.78 V and an irreversible Ag(I)-Ag(0) couple at E(pc) = -0.78 V (all potentials vs. ferrocene-ferrocenium).
    DOI:
    10.1039/dt9910000615
点击查看最新优质反应信息

同类化合物

()-2-(5-甲基-2-氧代苯并呋喃-3(2)-亚乙基)乙酸乙酯 (双(2,2,2-三氯乙基)) (乙基N-(1H-吲唑-3-基羰基)ethanehydrazonoate) (Z)-3-[[[2,4-二甲基-3-(乙氧羰基)吡咯-5-基]亚甲基]吲哚-2--2- (S)-(-)-5'-苄氧基苯基卡维地洛 (S)-(-)-2-(α-(叔丁基)甲胺)-1H-苯并咪唑 (S)-(-)-2-(α-甲基甲胺)-1H-苯并咪唑 (S)-氨氯地平-d4 (S)-8-氟苯并二氢吡喃-4-胺 (S)-4-(叔丁基)-2-(喹啉-2-基)-4,5-二氢噁唑 (S)-4-氯-1,2-环氧丁烷 (S)-3-(2-(二氟甲基)吡啶-4-基)-7-氟-3-(3-(嘧啶-5-基)苯基)-3H-异吲哚-1-胺 (S)-2-(环丁基氨基)-N-(3-(3,4-二氢异喹啉-2(1H)-基)-2-羟丙基)异烟酰胺 (SP-4-1)-二氯双(喹啉)-钯 (SP-4-1)-二氯双(1-苯基-1H-咪唑-κN3)-钯 (R,S)-可替宁N-氧化物-甲基-d3 (R,S)-六氢-3H-1,2,3-苯并噻唑-2,2-二氧化物-3-羧酸叔丁酯 (R)-(+)-5'-苄氧基卡维地洛 (R)-(+)-2,2'',6,6''-四甲氧基-4,4''-双(二苯基膦基)-3,3''-联吡啶(1,5-环辛二烯)铑(I)四氟硼酸盐 (R)-卡洛芬 (R)-N'-亚硝基尼古丁 (R)-DRF053二盐酸盐 (R)-4-异丙基-2-恶唑烷硫酮 (R)-3-甲基哌啶盐酸盐; (R)-2-苄基哌啶-1-羧酸叔丁酯 (N-(Boc)-2-吲哚基)二甲基硅烷醇钠 (N-{4-[(6-溴-2-氧代-1,3-苯并恶唑-3(2H)-基)磺酰基]苯基}乙酰胺) (E)-2-氰基-3-(5-(2-辛基-7-(4-(对甲苯基)-1,2,3,3a,4,8b-六氢环戊[b]吲哚-7-基)-2H-苯并[d][1,2,3]三唑-4-基)噻吩-2-基)丙烯酸 (E)-2-氰基-3-[5-(2,5-二氯苯基)呋喃-2-基]-N-喹啉-8-基丙-2-烯酰胺 (8α,9S)-(+)-9-氨基-七氢呋喃-6''-醇,值90% (6R,7R)-7-苯基乙酰胺基-3-[(Z)-2-(4-甲基噻唑-5-基)乙烯基]-3-头孢唑啉-4-羧酸二苯甲基酯 (6-羟基嘧啶-4-基)乙酸 (6,7-二甲氧基-4-(3,4,5-三甲氧基苯基)喹啉) (6,6-二甲基-3-(甲硫基)-1,6-二氢-1,2,4-三嗪-5(2H)-硫酮) (5aS,6R,9S,9aR)-5a,6,7,8,9,9a-六氢-6,11,11-三甲基-2-(2,3,4,5,6-五氟苯基)-6,9-甲基-4H-[1,2,4]三唑[3,4-c][1,4]苯并恶嗪四氟硼酸酯 (5R,Z)-3-(羟基((1R,2S,6S,8aS)-1,3,6-三甲基-2-((E)-prop-1-en-1-yl)-1,2,4a,5,6,7,8,8a-八氢萘-1-基)亚甲基)-5-(羟甲基)-1-甲基吡咯烷-2,4-二酮 (5E)-5-[(2,5-二甲基-1-吡啶-3-基-吡咯-3-基)亚甲基]-2-亚磺酰基-1,3-噻唑烷-4-酮 (5-(4-乙氧基-3-甲基苄基)-1,3-苯并二恶茂) (5-溴-3-吡啶基)[4-(1-吡咯烷基)-1-哌啶基]甲酮 (5-氯-2,1,3-苯并噻二唑-4-基)-氨基甲氨基硫代甲酸甲酯一氢碘 (5-氨基-6-氰基-7-甲基[1,2]噻唑并[4,5-b]吡啶-3-甲酰胺) (5-氨基-1,3,4-噻二唑-2-基)甲醇 (4aS-反式)-八氢-1H-吡咯并[3,4-b]吡啶 (4aS,9bR)-6-溴-2,3,4,4a,5,9b-六氢-1H-吡啶并[4,3-B]吲哚 (4S,4''S)-2,2''-环亚丙基双[4-叔丁基-4,5-二氢恶唑] (4-(4-氯苯基)硫代)-10-甲基-7H-benzimidazo(2,1-A)奔驰(德)isoquinolin-7一 (4-苄基-2-甲基-4-nitrodecahydropyrido〔1,2-a][1,4]二氮杂) (4-甲基环戊-1-烯-1-基)(吗啉-4-基)甲酮 (4-己基-2-甲基-4-nitrodecahydropyrido〔1,2-a][1,4]二氮杂) (4,5-二甲氧基-1,2,3,6-四氢哒嗪)